The role and regulation of friend of GATA-1 (FOG-1) during blood development in the zebrafish

  • Julio D. Amigo
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • Gabriele E. Ackermann
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • John J. Cope
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • Ming Yu
    Division of Hematology-Oncology, Children's Hospital Boston; and
  • Jeffrey D. Cooney
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • Dongdong Ma
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • Nathaniel B. Langer
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • Ebrahim Shafizadeh
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • George C. Shaw
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • Wyatt Horsely
    Division of Hematology-Oncology, Children's Hospital Boston; and
  • Nikolaus S. Trede
    Harvard Medical School, Boston;
  • Alan J. Davidson
    Harvard Medical School, Boston;
  • Bruce A. Barut
    Division of Hematology-Oncology, Children's Hospital Boston; and
  • Yi Zhou
    Harvard Medical School, Boston;
  • Sarah A. Wojiski
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • David Traver
    Division of Hematology-Oncology, Children's Hospital Boston; and
  • Tyler B. Moran
    Division of Hematology-Oncology, Children's Hospital Boston; and
  • George Kourkoulis
    Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Karl Hsu
    Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
  • John P. Kanki
    Harvard Medical School, Boston;
  • Dhvanit I. Shah
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • Hui Feng Lin
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • Robert I. Handin
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;
  • Alan B. Cantor
    Harvard Medical School, Boston;
  • Barry H. Paw
    Department of Medicine, Division of Hematology, Brigham & Women's Hospital, Boston;

説明

<jats:title>Abstract</jats:title><jats:p>The nuclear protein FOG-1 binds transcription factor GATA-1 to facilitate erythroid and megakaryocytic maturation. However, little is known about the function of FOG-1 during myeloid and lymphoid development or how FOG-1 expression is regulated in any tissue. We used in situ hybridization, gain- and loss-of-function studies in zebrafish to address these problems. Zebrafish FOG-1 is expressed in early hematopoietic cells, as well as heart, viscera, and paraspinal neurons, suggesting that it has multifaceted functions in organogenesis. We found that FOG-1 is dispensable for endoderm specification but is required for endoderm patterning affecting the expression of late-stage T-cell markers, independent of GATA-1. The suppression of FOG-1, in the presence of normal GATA-1 levels, induces severe anemia and thrombocytopenia and expands myeloid-progenitor cells, indicating that FOG-1 is required during erythroid/myeloid commitment. To functionally interrogate whether GATA-1 regulates FOG-1 in vivo, we used bioinformatics combined with transgenic assays. Thus, we identified 2 cis-regulatory elements that control the tissue-specific gene expression of FOG-1. One of these enhancers contains functional GATA-binding sites, indicating the potential for a regulatory loop in which GATA factors control the expression of their partner protein FOG-1.</jats:p>

収録刊行物

  • Blood

    Blood 114 (21), 4654-4663, 2009-11-19

    American Society of Hematology

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ